This page shows Evaxion AS (EVAX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Evaxion AS's revenue surged 125.1% year-over-year to $7.5M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Evaxion AS carries a low D/E ratio of 0.09, meaning only $0.09 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 5.85, Evaxion AS holds $5.85 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
While Evaxion AS generated -$6.6M in operating cash flow, capex of $11K consumed most of it, leaving -$6.6M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Evaxion AS generates a -45.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100.
Evaxion AS passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Evaxion AS generates $0.86 in operating cash flow (-$6.6M OCF vs -$7.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Evaxion AS generated $7.5M in revenue in fiscal year 2025. This represents an increase of 125.1% from the prior year.
Evaxion AS reported -$7.7M in net income in fiscal year 2025. This represents an increase of 27.1% from the prior year.
Cash & Balance Sheet
Evaxion AS generated -$6.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 48.7% from the prior year.
Evaxion AS held $23.2M in cash against $1.6M in long-term debt as of fiscal year 2025.
Evaxion AS had 417M shares outstanding in fiscal year 2025. This represents an increase of 494.6% from the prior year.
Margins & Returns
Evaxion AS's net profit margin was -102.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 213.6 percentage points from the prior year.
Evaxion AS's ROE was -45.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
Evaxion AS invested $11K in capex in fiscal year 2025, funding long-term assets and infrastructure.
EVAX Income Statement
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $37K | N/A | $154K | N/A | $0 | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | $39K | N/A | $40K | N/A | $44K | N/A | N/A |
| Income Tax | N/A | -$195K | N/A | -$199K | N/A | -$225K | N/A | N/A |
| Net Income | N/A | -$4.8M | N/A | -$6.2M | N/A | -$5.7M+8.9% | -$6.2M | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EVAX Balance Sheet
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $28.4M+26.5% | $22.4M+79.8% | $12.5M-18.0% | $15.2M+18.2% | $12.9M-23.1% | $16.8M | N/A | $22.0M |
| Current Assets | $24.9M+37.0% | $18.2M+107.4% | $8.8M-18.1% | $10.7M+28.1% | $8.3M-26.5% | $11.4M | N/A | $17.0M |
| Cash & Equivalents | $23.2M+57.6% | $14.7M+147.7% | $6.0M-25.5% | $8.0M+43.2% | $5.6M-21.6% | $7.1M | N/A | $13.2M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | $2.0M | N/A | N/A | $2.8M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $11.4M-29.9% | $16.2M+14.8% | $14.1M+1.1% | $14.0M-20.7% | $17.6M+23.9% | $14.2M | N/A | $13.7M |
| Current Liabilities | $4.3M-20.0% | $5.3M+21.8% | $4.4M+14.3% | $3.8M-46.1% | $7.1M+74.9% | $4.0M | N/A | $3.8M |
| Long-Term Debt | $1.6M-6.1% | $1.7M+5.7% | $1.6M-7.4% | $1.8M-7.7% | $1.9M-2.6% | $1.9M | N/A | $2.0M |
| Total Equity | $17.0M+173.7% | $6.2M+476.9% | -$1.7M-231.8% | $1.3M+126.5% | -$4.7M-286.5% | $2.5M-61.4% | $6.6M-20.8% | $8.3M |
| Retained Earnings | -$126.2M-1.0% | -$124.9M-5.4% | -$118.5M-4.9% | -$113.0M-4.6% | -$108.0M-28.1% | -$84.3M | N/A | -$85.8M |
EVAX Cash Flow Statement
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EVAX Financial Ratios
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | -13056.8% | N/A | -4024.7% | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | -77.6% | N/A | -494.7% | N/A | -224.2%-129.3pp | -94.9% | N/A |
| Return on Assets | N/A | -21.5% | N/A | -40.7% | N/A | -33.9% | N/A | N/A |
| Current Ratio | 5.85+2.4 | 3.42+1.4 | 2.01-0.8 | 2.80+1.6 | 1.18-1.6 | 2.81 | N/A | 4.51 |
| Debt-to-Equity | 0.09-0.2 | 0.28+1.3 | -0.98-2.4 | 1.40+1.8 | -0.40-1.2 | 0.77 | N/A | 0.24 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Evaxion AS's annual revenue?
Evaxion AS (EVAX) reported $7.5M in total revenue for fiscal year 2025. This represents a 125.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Evaxion AS's revenue growing?
Evaxion AS (EVAX) revenue grew by 125.1% year-over-year, from $3.3M to $7.5M in fiscal year 2025.
Is Evaxion AS profitable?
No, Evaxion AS (EVAX) reported a net income of -$7.7M in fiscal year 2025, with a net profit margin of -102.4%.
How much debt does Evaxion AS have?
As of fiscal year 2025, Evaxion AS (EVAX) had $23.2M in cash and equivalents against $1.6M in long-term debt.
What is Evaxion AS's net profit margin?
Evaxion AS (EVAX) had a net profit margin of -102.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Evaxion AS's return on equity (ROE)?
Evaxion AS (EVAX) has a return on equity of -45.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Evaxion AS's free cash flow?
Evaxion AS (EVAX) generated -$6.6M in free cash flow during fiscal year 2025. This represents a 48.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Evaxion AS's operating cash flow?
Evaxion AS (EVAX) generated -$6.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Evaxion AS's total assets?
Evaxion AS (EVAX) had $28.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Evaxion AS's capital expenditures?
Evaxion AS (EVAX) invested $11K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Evaxion AS's current ratio?
Evaxion AS (EVAX) had a current ratio of 5.85 as of fiscal year 2025, which is generally considered healthy.
What is Evaxion AS's debt-to-equity ratio?
Evaxion AS (EVAX) had a debt-to-equity ratio of 0.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Evaxion AS's return on assets (ROA)?
Evaxion AS (EVAX) had a return on assets of -27.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Evaxion AS's cash runway?
Based on fiscal year 2025 data, Evaxion AS (EVAX) had $23.2M in cash against an annual operating cash burn of $6.6M. This gives an estimated cash runway of approximately 42 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Evaxion AS's Piotroski F-Score?
Evaxion AS (EVAX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Evaxion AS's earnings high quality?
Evaxion AS (EVAX) has an earnings quality ratio of 0.86x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Evaxion AS?
Evaxion AS (EVAX) scores 60 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.